Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature
© Tran et al; licensee BioMed Central Ltd. 2008
Received: 06 August 2007
Accepted: 10 November 2008
Published: 10 November 2008
Streptococcus intermedius is a member of the Streptococcus anginosus group. Clinical disease with S. intermedius is characterized by abscess formation and rarely endocarditis. Identification of Streptococcus intermedius is difficult, leading to the development of molecular methods to more accurately identify and characterize this organism.
Over a period of 6 months we encountered three cases of invasive Streptococcus intermedius infection presenting as hepatic abscesses, brain abscess, and endocarditis. We confirmed our microbiologic diagnosis through 16S sequencing and found a common virulence gene in each case.
Our report illustrates three different clinical manifestations due to Streptococcus intermedius infection that can be encountered in healthy individuals in a community hospital setting. To our knowledge, this is the first case of Streptococcus intermedius endocarditis confirmed by 16S sequencing analysis. The use of molecular methods may allow a better understanding of the epidemiology and pathogenesis of this organism.
Streptococcus intermedius is a member of the Streptococcus anginosus group (SAG), also known as the "Streptococcus milleri" group. A variety of clinical diseases have been associated with infection with the different members of the SAG . S. intermedius has a tendency to cause abscess formation commonly found in the liver and brain, but is rarely the etiologic agent in infective endocarditis [2–4]. Furthermore, members of the SAG are difficult to distinguish on the basis of phenotypic characteristics . This prompted the development of genotypic methods employing the polymerase chain reaction (PCR) to aid in the speciation of these organisms. We report three varied cases of infection caused by S. intermedius that were encountered over a short time period in a community-based teaching hospital. Two cases presented with multiple liver abscesses and bacteremia caused by S. intermedius, with one case complicated by the development of endocarditis. The third patient presented with a brain abscess secondary to chronic sinusitis.
Case presentation #1
A 24 year-old male presented to his primary care physician with an 8-day history of fevers, chills, and myalgias. He complained of a sore throat and worsening headache with neck pain for the past 2 days. He also had abdominal pain, constipation, and bloating throughout the week, without nausea or vomiting. At his primary care physician's office, he had a temperature of 104°F and was sent to the emergency department for further evaluation. On admission, the patient was awake and oriented, but appeared lethargic and pale. Vital signs included a temperature of 103°F, blood pressure of 112/51 mmHg, pulse of 112/minute, respiratory rate of 22/minute, and an oxygen saturation of 88% on room air. The physical exam revealed minimal crackles at the lung bases and mid-abdominal tenderness without peritoneal signs or hepatosplenomegaly. The rest of the physical exam was unremarkable. Laboratory data included a white blood count of 14,900/μL with 77% neutrophils and 10% bands, hemoglobin of 14.9 gm/dL, platelet count of 244,000/cmm, and a C-reactive protein of 39.9 mg/L. Liver enzymes, BUN, creatinine, and electrolyte panel were within normal limits. A monospot and influenza A and B were negative. A lumber puncture performed in the emergency department did not show evidence of meningitis. A chest x-ray showed a left basilar infiltrate.
Case presentation #2
The patient was started on imipenem 500 mg every 8 hours. General surgery was consulted and performed an exploratory laparotomy with surgical drainage of 4 abscesses and a cholecystectomy. Blood cultures on admission grew viridans group streptococci. Surgical cultures also grew viridans group streptococci with negative anaerobic cultures. The antibiotic regimen was changed to ceftriaxone 2 g once daily. The patient continued to follow up with the Infectious Diseases Clinic. After a total of 6 months of cephalosporin therapy, repeat CT scan of the abdomen showed resolution of the liver abscesses.
Case presentation #3
A 16 year-old female with a history of chronic sinusitis presented with worsening frontal headache and frequent episodes of bloody sinus drainage over a period of six months. She was placed on antihistamines and steroid nasal spray without relief. The patient had difficulty concentrating in school and was started on atomoxetine for possible ADHD. She denied fevers, decreased level of consciousness, and focal neurological signs. An outpatient CT of the brain showed a left frontal mass, and complete opacification of the bilateral frontal, bilateral ethmoid, left maxillary, and right sphenoid sinuses. An MRI was performed which showed a thick-walled, ring-enhancing, frontal abscess, reflecting as an intracranial extension of a large mucocele. She was subsequently sent to the emergency department for further evaluation. Vital signs include a temperature of 97°F, blood pressure of 117/75, pulse 84/minute, and respiratory rate of 14/minute. Physical exam was unremarkable with a GCS of 15 and no neurological deficits. Laboratory data showed a white blood count of 8,100/μL, hemoglobin of 12.5 g/dL, and platelets of 435,000/L. Electrolyte panel, liver function tests, BUN, and creatinine were within normal limits. She was placed on ceftriaxone 2 g every 12 hours and metronidazole 500 mg every 6 hours.
Written consent was obtained from all patients. Michigan State University's Institutional Review Board has waived the need for approval.
Direct Gram stain of the abscess drainage of all three patients and positive blood cultures revealed Gram-positive cocci in chains. Cultures on sheep blood agar produced alpha-hemolytic colonies of Gram-positive cocci after 24 hours of incubation at 37°C. The isolates were presumptively identified as members of the Streptococcus anginosus group by phenotypic classification . Antibiotic susceptibility testing was performed by E-test on both blood and abscess drainage cultures. The isolate of case #1 was susceptible to penicillin (MIC ≤ 0.12 mg/L), ceftriaxone (MIC ≤ 0.12), cefotaxime (MIC ≤ 1.25), and vancomycin. The isolate was resistant to erythromycin and clindamycin. The blood and surgical abscess drainage cultures of case #2 revealed similar susceptibility patterns in that the isolate was susceptible to penicillin (MIC ≤ 0.032), ceftriaxone (MIC ≤ 0.064), and vancomycin with resistance to erythromycin and clindamycin. Tetracycline was not tested in both cases. The isolate from the brain abscess of case #3 did not have adequate growth to perform antibiotic susceptibilities.
Using the primer pair 8F and 1492R and the genomic DNA from each isolate, a nearly complete (> 1.4 kbp) 16S rRNA gene fragment was amplified by conventional PCR . For each isolate, the partial 16S rRNA-encoding gene sequence was 100% identical to the type strain of S. intermedius (GenBank accession number AF104671). In addition, all three isolates were positive in a PCR assay targeting the ily gene, which encodes for S. intermedius toxin intermedilysin .
The Streptococcus anginosus group (SAG), one of five groups collectively known as viridans group streptococci, consists of the species S. intermedius, S. anginosus, and S. constellatus . These organisms are commonly associated with purulent infections with abscess formation and less commonly the cause of endocarditis than other viridans streptococci [9–13]. S. intermedius has an apparent tropism for the brain and liver, whereas S. anginosus and S. constellatus have been isolated from a wider range of sites and infections [2, 14]. The three cases presented here highlight a common presentation of S. intermedius (liver and brain abscesses) and a rare complication (endocarditis).
The identification and classification of streptococci based on hemolytic and Lancefield grouping reactions is cumbersome and lacks discriminatory power. Whiley, et. al. developed phenotypic methods to better differentiate the SAG. Commercially available systems based on these phenotypic tests are widely used and provide a more rapid characterization of each species, but accuracy remains variable [15, 16]. This has led to the development of molecular techniques, such as PCR sequencing, to increase the accuracy of identification and clinical profiling [1, 7, 17, 18]. Furthermore, several species-specific genes have been targeted for the development of PCR-based assays for the identification of the SAG organisms [7, 18]. Intermedilysin (ILY) is a human-specific cytolysin that directly damages human hepatic cells and is implicated as a potential important virulence factor in causing deep-seated abscesses . The ily gene has been shown to be specific for S. intermedius. The assay can be used for rapid identification through the use of PCR with the ily gene as a species marker gene, which was amplified on all three isolates .
Pyogenic liver abscesses are an uncommon, but potentially life-threatening, infection. The first cases of SAG hepatic abscesses were reported in 1975 . Later, a study in 1981 found SAG to be the most common cause of hepatic abscesses . A prospective study by Coreedoira, et. al. compared the incidence and clinical features of SAG liver abscess to liver abscesses caused by other organisms. Members of SAG were most commonly isolated, with S. intermedius being the most frequent species. Abscesses also tended to be monomicrobial and the duration of symptoms were longer when compared to other organisms. However, there were no differences in mortality, duration of antibiotics, or complications. The majority of patients required surgical or percutaneous drainage of the abscesses for cure as was the case for our patients, whereas 20% of patients were treated with antimicrobials alone .
Members of the SAG are rare causes of endocarditis. Previous studies on infective endocarditis caused by SAG have relied on phenotypic methods for identification. Sussman, et. al. studied 36 patients with viridans streptococcal endocarditis, and identification at the species level was determined by using biochemical tests established by Facklam . Four of the cases were found to be S. intermedius. Sixteen isolates from the study were sent to five institutions to confirm identification. Not surprisingly, only 3 were characterized as the same species by all five institutions . Another retrospective study found 29 cases of endocarditis due to SAG, and only 3 were identified as S. intermedius . However, the commercial method used in this case, Rapid 32 ID Strep System (bioMérieux), has been shown to be the least accurate in identifying S. intermedius . A more recent study by Woo, et. al. applied 16S rRNA sequencing to 6 cases of SAG endocarditis, all of which were identified as S. anginosus . To our knowledge, we report the first case of S. intermedius endocarditis confirmed by 16S sequence analysis.
Brain abscesses can result via spread from a contiguous focus of infection, hematogenous spread, or as a result from head trauma or neurosurgery . Mortality and morbidity have reduced over the decades in the advent of newer antibiotic therapies and early recognition with CT scans and MRIs . Several case series have defined the clinical characteristics of patients with brain abscesses. All ages are affected with a male predominance. Headache, fever, and mental status changes are the most common initial presenting features, although only one-third of patients have the classic triad. The majority of abscesses are solitary and occur in the frontal lobe. Surgery is required in most patients, and the duration of antibiotics range from 4 to 8 weeks [26–31]. The SAG has been recently recognized as a common cause of brain abscesses, which were collectively identified with other streptococci as viridans group streptococci in prior studies [29, 31]. Several retrospective reviews and case reports have identified S. intermedius as a significant pathogen among the SAG in the development of brain abscesses [1, 2, 32, 33]. However, no study has compared S. intermedius brain abscesses with other members of the SAG or with other bacterial causes.
A unique feature of our cases was the lack of underlying medical problems in our two patients with liver abscesses. Infections caused by SAG are not common in previously healthy individuals. An underlying condition, such as diabetes, cirrhosis, or cancer, is associated with the majority of patients [12, 34, 35]. Neither of our patients with liver abscesses had chronic illnesses or evidence of immunosuppression. The third case with brain abscess, however, had chronic sinusitis, which is one of the most common predisposing factors [29, 31]. The presentation of these cases highlights the range of infection caused by S. intermedius that can be encountered in a community setting. Our findings indicate that infections with S. intermedius and the other members of the SAG may be more common that previously appreciated.
S. intermedius commonly causes liver and brain abscesses but rarely endocarditis. Our cases demonstrate how S. intermedius can cause severe illness in otherwise healthy individuals. Because species in the Streptococcus anginosus group are difficult to identify by routine biochemical tests, newer molecular methods are available to more accurately identify each species. As newer genotyping techniques develop, the clinical characteristics of this diverse group are becoming better understood. These three cases highlight both common and uncommon presentations of S. intermedius infection and the utilization of these methods to confirm a rare case of S. intermedius endocarditis. Additional studies will be required to more precisely determine the prevalence and range of clinical disease due to infection with the SAG organisms.
No funding source.
- Claridge JE, Attorri S, Musher DM, Hebert J, Dunbar S: Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis. 2001, 32 (10): 1511-1515.View ArticlePubMedGoogle Scholar
- Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM: Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. Journal of clinical microbiology. 1992, 30 (1): 243-244.PubMedPubMed CentralGoogle Scholar
- Woo PC, Tse H, Chan KM, Lau SK, Fung AM, Yip KT, Tam DM, Ng KH, Que TL, Yuen KY: "Streptococcus milleri " endocarditis caused by Streptococcus anginosus. Diagn Microbiol Infect Dis. 2004, 48 (2): 81-88.View ArticlePubMedGoogle Scholar
- Rashid RM, Salah W, Parada JP: "Streptococcus milleri " aortic valve endocarditis and hepatic abscess. Journal of Medical Microbiology. 2007, 56: 280-282.View ArticlePubMedGoogle Scholar
- Murray P: Bacteriology. Manual of Clinical Microbiology. Edited by: Murray P. 2003, Washington, D. C.: Amer Society for Microbiology, 1: 411-416. 8Google Scholar
- Schmidt TM, Relman DA: Phylogenetic identification of uncultured pathogens using ribosomal RNA sequences. Methods Enzymol. 1994, 235: 205-22.View ArticlePubMedGoogle Scholar
- Goto T, Nagamune H, Miyazaki A, Kawamura Y, Ohnishi O, Hattori K, Ohkura K, Miyamoto K, Akimoto S, Ezaki T, et al: Rapid identification of Streptococcus intermedius by PCR with the ily gene as a species marker gene. J Med Microbiol. 2002, 51 (2): 178-186.View ArticlePubMedGoogle Scholar
- Whiley RA, Beighton D: Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int J Syst Bacteriol. 1991, 41: 1-5.View ArticlePubMedGoogle Scholar
- Murray HW, Gross KC, Masur H, Roberts RB: Serious infections caused by Streptococcus milleri. Am J Med. 1978, 64 (5): 759-764.View ArticlePubMedGoogle Scholar
- Shlaes DM, Lerner PI, Wolinsky E, Gopalakrishna KV: Infections due to Lancefield group F and related Streptococci (S. milleri, S. anginosus). Medicine (Baltimore). 1981, 60 (3): 197-207.View ArticleGoogle Scholar
- Singh KP, Morris A, Lang SD, MacCulloch DM, Bremner DA: Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N Z Med J. 1988, 101 (859): 813-816.PubMedGoogle Scholar
- Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL: Clinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis. 1991, 23 (6): 659-666.View ArticlePubMedGoogle Scholar
- Salavert M, Gomez L, Rodriguez-Carballeira M, Xercavins M, Freixas N, Garau J: Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis. 1996, 15 (5): 365-371.View ArticlePubMedGoogle Scholar
- Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group". Journal of clinical microbiology. 1990, 28 (7): 1497-1501.PubMedPubMed CentralGoogle Scholar
- Alam S, Brailsford SR, Whiley RA, Beighton D: PCR-Based methods for genotyping viridans group streptococci. Journal of clinical microbiology. 1999, 37 (9): 2772-2776.PubMedPubMed CentralGoogle Scholar
- Limia A, Alarcon T, Jimenez ML, Lopez-Brea M: Comparison of three methods for identification of Streptococcus milleri group isolates to species level. Eur J Clin Microbiol Infect Dis. 2000, 19 (2): 128-131.View ArticlePubMedGoogle Scholar
- Bartie KL, Wilson MJ, Williams DW, Lewis MA: Macrorestriction fingerprinting of "Streptococcus milleri " group bacteria by pulsed-field gel electrophoresis. Journal of clinical microbiology. 2000, 38 (6): 2141-2149.PubMedPubMed CentralGoogle Scholar
- Takao A, Nagamune H, Maeda N: Identification of the anginosus group within the genus Streptococcus using polymerase chain reaction. FEMS Microbiol Lett. 2004, 233 (1): 83-89.View ArticlePubMedGoogle Scholar
- Macey MG, Whiley RA, Miller L, Nagamune H: Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius. Infection and immunity. 2001, 69 (10): 6102-6109.View ArticlePubMedPubMed CentralGoogle Scholar
- Bateman NT, Eykyn SJ, Phillips I: Pyogenic liver abscess caused by Streptococcus milleri. Lancet. 1975, 1 (7908): 657-659.View ArticlePubMedGoogle Scholar
- Moore-Gillon JC, Eykyn S, Phillips I: Microbiology of pyogenic liver abscess. British Medical Journal. 1981, 283: 819-821.View ArticlePubMedPubMed CentralGoogle Scholar
- Corredoira J, Casariego E, Moreno C, Villanueva L, Lopez , Varela J, Rodriguez A, Alonso P, Coira A: Prospective study of Streptococcus milleri hepatic abscess. Eur J Clin Microbiol Infect Dis. 1998, 17 (8): 556-660.PubMedGoogle Scholar
- Facklam RR: Physiological differentiation of viridans streptococci. Journal of clinical microbiology. 1977, 5: 184-201.PubMedPubMed CentralGoogle Scholar
- Sussman JI, Baron EJ, Tenenbaum MJ, Kaplan MH, Greenspan J, Facklam RR, Tyburski MB, Goldman MA, Kanzer BF, Pizzarello RA: Viridans streptococcal endocarditis: clinical, microbiological, and echocardiographic correlations. J Infect Dis. 1986, 154 (4): 597-603.View ArticlePubMedGoogle Scholar
- Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL: Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France. Arch Intern Med. 2002, 162 (21): 2450-2456.View ArticlePubMedGoogle Scholar
- Kao P, Tseng H, Liu C, Su S, Lee C: Brain abscess: clinical analysis of 53 cases. J Microbiol Immunol Infect. 2003, 36: 129-136.PubMedGoogle Scholar
- Mathisen G, Johnson JP: Brain abscess. Clinical Infectious Diseases. 1997, 25: 763-781.View ArticlePubMedGoogle Scholar
- Su T, Lin Y, Lu C, Chang W, Liliang P, Rau C, Liang C, Tsai Y, Lee T, Chen H: Streptococcal brain abscess: analysis of clinical features in 20 patients. Surg Neurol. 2001, 56: 189-194.View ArticlePubMedGoogle Scholar
- Roche M, Humphreys H, Smyth E, Phillips J, Cunney R, McNamara E, O'Brien D, McArdle O: A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect. 2003, 9: 803-809.View ArticlePubMedGoogle Scholar
- Kowlessar PI, O'Connell NH, Mitchell RD, Elliott S, Elliott TSJ: Management of patients with Streptococcus milleri brain abscess. Journal of Infection. 2006, 52: 443-450.View ArticlePubMedGoogle Scholar
- Carpenter J, Stapleton S, Holliman R: Retrospective analysis of 49 cases of brain abscess and review of literature. Eur J Clin Microbiol Infect Dis. 2007, 26: 1-11.View ArticlePubMedGoogle Scholar
- Yamamoto M, Fukushima T, Ohshiro S, Go Y, Tsugu H, Kono K, Tomonaga M: Brain abscess caused by Streptococcus intermedius: two case reports. Surg Neurol. 1999, 51: 219-222.View ArticlePubMedGoogle Scholar
- Wagner KW, Schon R, Schumacher M, Schmelzeisen R, Schulze D: Case report: brain and liver abscess caused by oral infection with Streptococcus intermedius. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006, 102: e21-e23.View ArticlePubMedGoogle Scholar
- Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB: Bacteremia involving the "Streptococcus milleri " group: analysis of 19 cases. Clin Infect Dis. 1994, 19 (4): 704-713.View ArticlePubMedGoogle Scholar
- Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of bacteremia involving the "Streptococcus milleri " group: 51 cases and review. Clin Infect Dis. 1998, 27 (2): 385-387.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/8/154/prepub